NuCana PLC (NCNA)

1.59 +0.05 (+3.25%) USD  |  NASDAQ  |  Nov 04, 16:00
1.64 +0.05 (+3.14%) After-Hours: 20:00
More

NuCana Debt to Equity Ratio

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to . Upgrade now.
Date Value

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

--
Minimum
--
Maximum
--
Average
--
Median

Debt to Equity Ratio Benchmarks

Adaptimmune Therapeutics PLC 0.2592
Biodexa Pharmaceuticals PLC --
Verona Pharma PLC --
Autolus Therapeutics PLC --
Mereo BioPharma Group PLC --

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly) 25.38M
Total Liabilities (Quarterly) 20.58M
Shareholders Equity (Quarterly) 4.806M